Filed by: Berry Global Group, Inc.
Commission File No.: 001-35672
Pursuant to Rule 425 under the Securities Act of 1933
Subject Company:
Glatfelter Corporation (Commission File No.: 001-03560)
Below is a communication made by Berry Global Group, Inc. on February 7, 2024:
Dear Glatfelter team,
I wanted to personally share my excitement
about the planned spin-off and combination of Berry’s Health, Hygiene and Specialties Global
Nonwovens and Films business (“HHNF”) with Glatfelter.
Like us, Glatfelter prides itself
on world-class people, professionalism, commitment, and know-how to deliver innovative solutions. I have come to know the Glatfelter team
even better over recent months, and this has only reinforced my belief that our two companies are a perfect fit – both commercially
and culturally.
This transaction provides a unique
opportunity to create a global leader in the growing specialty materials industry, supplying our customers around the world from a global
network of manufacturing locations with the most talented employees in the industry. Berry HHNF and Glatfelter have significantly complementary
products serving global healthcare, hygiene and specialties markets. Together, we will increase our relevance as a supplier of choice
through meaningful innovation, superior service, and reliability to provide customers with value-additive product offerings.
Looking ahead, what I’m most
excited about is our drivers for growth. The field of specialty materials is rapidly evolving, and each of our respective organizations
is positioned to benefit from global growth trends arising from the growing middle class, an aging population, the increasing globalization
of supply chains, and a heightened focus on personal hygiene, sustainability, and safety products. I am confident that together, we will
be even better positioned to capitalize on these mega trends and drive growth for employees, customers, and shareholders alike.
I am honored to lead the combined
company as CEO once the transaction closes, which is expected to occur in the second half of 2024, and look forward to meeting many of
you over the coming months as we work to realize the many benefits of this combination. Until then, thank you for everything you do that
has made Glatfelter such a great business.
Sincerely,
Curt Begle
President, Health, Hygiene, &
Specialties
Cautionary Statement Concerning Forward-Looking
Statements
Statements
in this communication that are not historical, including statements relating the expected timing, completion and effects of the proposed
transaction between Berry and Glatfelter, are considered “forward looking” within the meaning of the federal securities laws
and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking
statements because they contain words such as “believes,” “expects,” “may,” “will,” “should,”
“would,” “could,” “seeks,” “approximately,” “intends,” “plans,”
“estimates,” “projects,” “outlook,” “anticipates” or “looking forward,” or
similar expressions that relate to strategy, plans, intentions, or expectations. All statements relating to estimates and statements about
the expected timing and structure of the proposed transaction, the ability of the parties to complete the proposed transaction, benefits
of the transaction, including future financial and operating results, the combined company’s plans, objectives, expectations and
intentions, and other statements that are not historical facts are forward-looking statements. In addition, senior management of Berry
and Glatfelter, from time to time make forward-looking public statements concerning expected future operations and performance and other
developments.
Actual results
may differ materially from those that are expected due to a variety of factors, including without limitation: the occurrence of any event,
change or other circumstances that could give rise to the termination of the proposed transaction; the risk that Glatfelter shareholders
may not approve the transaction proposals; the risk that the necessary regulatory approvals may not be obtained or may be obtained subject
to conditions that are not anticipated; risks that any of the other closing conditions to the proposed transaction may not be satisfied
in a timely manner; risks that the anticipated tax treatment of the proposed transaction is not obtained; risks related to potential litigation
brought in connection with the proposed transaction; uncertainties as to the timing of the consummation of the proposed transaction; unexpected
costs, charges or expenses resulting from the proposed transaction; risks and costs related to the implementation of the separation of
Berry’s HH&S global nonwovens and films business into a new entity (“Spinco”), including timing anticipated to complete
the separation; any changes to the configuration of the businesses included in the separation if implemented; the risk that the integration
of the combined companies is more difficult, time consuming or costly than expected; risks related to financial community and rating agency
perceptions of each of Berry and Glatfelter and its business, operations, financial condition and the industry in which they operate;
risks related to disruption of management time from ongoing business operations due to the proposed transaction; failure to realize the
benefits expected from the proposed transaction; effects of the announcement, pendency or completion of the proposed transaction on the
ability of the parties to retain customers and retain and hire key personnel and maintain relationships with their counterparties, and
on their operating results and businesses generally; and other risk factors detailed from time to time in Glatfelter’s and Berry’s
reports filed with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and other
documents filed with the SEC. These risks, as well as other risks associated with the proposed transaction, will be more fully discussed
in the registration statements, proxy statement/prospectus and other documents that will be filed with the SEC in connection with the
proposed transaction. The foregoing list of important factors may not contain all of the material factors that are important to you. New
factors may emerge from time to time, and it is not possible to either predict new factors or assess the potential effect of any such
new factors. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are based upon information
available as of the date hereof. All forward-looking statements are made only as of the date hereof and neither Berry nor Glatfelter undertake
any obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise, except as
otherwise required by law.
Additional Information and Where to
Find It
This communication
may be deemed to be solicitation material in respect of the proposed transaction between Berry and Glatfelter. In connection with the
proposed transaction, Berry and Glatfelter intend to file relevant materials with the SEC, including a registration statement on Form
S-4 by Glatfelter that will contain a proxy statement/prospectus relating to the proposed transaction. In addition, Spinco expects to
file a registration statement in connection with its separation from Berry. This communication is not a substitute for the registration
statements, proxy statement/prospectus or any other document which Berry and/or Glatfelter may file with the SEC. STOCKHOLDERS OF BERRY
AND GLATFELTER ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING THE REGISTRATION STATEMENT AND PROXY STATEMENT/PROSPECTUS,
BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain
copies of the registration statements and proxy statement/prospectus (when available) as well as other filings containing information
about Berry and Glatfelter, as well as the Spinco, without charge, at the SEC’s website, http://www.sec.gov. Copies of documents
filed with the SEC by Berry or the Spinco will be made available free of charge on Berry’s investor relations website at https://ir.berryglobal.com.
Copies of documents filed with the SEC by Glatfelter will be made available free of charge on Glatfelter's investor relations website
at https://www.glatfelter.com/investors.
No Offer or Solicitation
This communication
is for informational purposes only and is not intended to and does not constitute an offer to sell, or the solicitation of an offer to
sell, subscribe for or buy, or a solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer
of securities in any jurisdiction in which such offer, sale or solicitation would be unlawful, prior to registration or qualification
under the securities laws of any such jurisdiction. No offer or sale of securities shall be made except by means of a prospectus meeting
the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.
Participants in Solicitation
Berry and
its directors and executive officers, and Glatfelter and its directors and executive officers, may be deemed to be participants in the
solicitation of proxies from the holders of Glatfelter capital stock and/or the offering of securities in respect of the proposed transaction.
Information about the directors and executive officers of Berry, including a description of their direct or indirect interests, by security
holdings or otherwise, is set forth under the caption “Security Ownership of Beneficial Owners and Management” in the definitive
proxy statement for Berry’s 2024 Annual Meeting of Stockholders, which was filed with the SEC on January 4, 2024 (https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/0001378992/000110465924001073/tm2325571d6_def14a.htm).
Information about the directors and executive officers of Glatfelter including a description of their direct or indirect interests, by
security holdings or otherwise, is set forth under the caption “Ownership of Company Stock” in the proxy statement for Glatfelter's
2023 Annual Meeting of Shareholders, which was filed with the SEC on March 31, 2023 (https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/0000041719/000004171923000012/glt-20230331.htm).
In addition, Curt Begle, the current President of the Berry’s Health, Hygiene & Specialties Division, will be appointed as Chief
Executive Officer of the combined company. Investors may obtain additional information regarding the interest of such participants by
reading the proxy statement/prospectus regarding the proposed transaction when it becomes available.
Glatfelter (NYSE:GLT)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Glatfelter (NYSE:GLT)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024